Endogenous TSH levels at the time of 131I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality.
about
Multiple-factor analysis of the first radioactive iodine therapy in post-operative patients with differentiated thyroid cancer for achieving a disease-free status.Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?Pediatric papillary thyroid cancer: current management challengesEvaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients.
P2860
Endogenous TSH levels at the time of 131I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@en
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@nl
type
label
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@en
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@nl
prefLabel
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@en
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@nl
P2093
P2860
P1476
Endogenous TSH levels at the t ...... roid cancer-related mortality.
@en
P2093
Alexis Vrachimis
Burkhard Riemann
Christoph Reiners
Frederik A Verburg
P2860
P2888
P356
10.1007/S00259-015-3223-2
P577
2015-10-23T00:00:00Z